4:32
Behind the Study: DLL3, ASC1, TTF-1 & Ki-67 in Precision Medicine for SCLC | Oncotarget
Oncotarget
2:34
Precision Medicine in SCLC: DLL3, ASC1, TTF-1, and Ki-67 Expression | Oncotarget
1:56
Serum Tumor Markers in NSCLC Management | Oncotarget
1:23
From Osimertinib to Preemptive Combinations | Oncotarget
1:12
Lazarus Effect in Patient Treated with Osimertinib for NSCLC with Leptomeningeal Disease |Oncotarget
1:16
Obesity Paradox and Lung Cancer, Metformin-based Therapeutic Opportunity? | Oncotarget
1:17
Updates on MET Targeted Therapy for EXON 14 Mutations in Lung Cancer | Oncotarget
2:40
Value of Chemotherapy Post Immunotherapy in Stage IV Non-Small Cell Lung Cancer (NSCLC) | Oncotarget
2:12
Angulin-1/LSR Downregulation Induces Malignancy in A549 Lung Adenocarcinoma Cells | Oncotarget
2:06
Polyisoprenylated Cysteinyl Amide Inhibitors Deplete G-Proteins in Cancer Cell Lines | Oncotarget
2:23
Tumor Hyaluronan as Novel Non-Small Cell Lung Cancer Biomarker: Retrospective Study | Oncotarget
1:01
Novel KEAP1/NRF2 Target Gene Regulating Ferroptosis and Radioresistance in Lung Cancers | Oncotarget
1:48
Therapeutic Efficacy of H2aL2a, H3L3 in Xenograft Models of Human Breast, Lung Cancer | Oncotarget
5:47
Molecular Characterization of Lung Carcinomas Expressing KK-LC-1 | Oncotarget
1:18
Real-World Treatment Patterns of Alectinib in Unselected Spanish ALK+ NSCLC Patients | Oncotarget
4:38
IGF-pathway Biomarkers and Lung Cancer | Oncotarget
Genetic Drivers of Lung Cancer by Number of Mutations | Oncotarget
0:58
Oncotarget | Multisite Cohort Study of Mutational Burden in Lung Cancer
0:52
Oncotarget | Characterization of KK-LC-1 in Lung Cancer
0:54
Oncotarget | A Retrospective Study of ALK Rearrangement in Patients With aNSCLC
0:55
Oncotarget: Comparison of Lung Cancer Cells in 2D and 3D Culture Conditions
Oncotarget: mTORC1 and PLK1 inhibition in adenocarcinoma NSCLC
15:17
Oncotarget: Retaining nanomolar potency in lung cancer with therapy-refractory mutations
0:46
Oncotarget: LP-184 Retains Potency in Refractory Lung Cancer
4:20
Geisel School of Medicine's and University of Texas's Dr. Dmitrovsky talks with Oncotarget
6:58
Oncotarget: Survival in patients with lung adenocarcinoma harboring "niche" mutations
6:55
Oncotarget: A chance for targeting cancer stem cells in human non-small cell lung cancer?
